版本:
中国

BRIEF-Moleculin receives Orphan Drug designation for Annamycin to treat acute myeloid leukemia

March 22 Moleculin Biotech Inc:

* Moleculin receives Orphan Drug designation for Annamycin for the treatment of acute myeloid leukemia Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐